Hallmark of IgA nephropathy is
**Question:** Hallmark of IgA nephropathy is
A. Mesangial immune complex deposition
B. Thrombocytopenia
C. Renal insufficiency
D. Hematuria
**Core Concept:** IgA nephropathy (IgAN) is a common chronic renal disease characterized by immune complex deposition in the glomerulus. IgAN is primarily caused by the deposition of IgA immune complexes, which leads to inflammation and damage to the glomerular mesangium.
**Why the Correct Answer is Right:** The correct answer (A) is right because it highlights the primary pathological feature of IgA nephropathy, which is the deposition of IgA immune complexes in the mesangium. This leads to glomerular inflammation and damage, ultimately resulting in renal dysfunction and proteinuria.
**Why Each Wrong Option is Incorrect:**
Option B (Thrombocytopenia) is incorrect because thrombocytopenia is a rare manifestation of IgA nephropathy and not a hallmark feature. It may occur due to the nephrotic range proteinuria, but is not directly related to the primary pathological process of IgA immune complex deposition.
Option C (Renal insufficiency) is incorrect because renal insufficiency is a consequence of the disease progression, rather than a defining feature. The primary pathological process in IgA nephropathy is immune complex deposition, which leads to glomerular inflammation and damage, resulting in renal impairment over time.
Option D (Hematuria) is incorrect because hematuria is a common finding but not a hallmark feature of IgA nephropathy. It is often present in early stages of the disease but does not specifically define the disease. The hallmark feature is the immune complex deposition and subsequent inflammation and damage to the glomeruli.
**Clinical Pearl:** IgA nephropathy is a crucial topic to understand for medical students, residents, and practicing physicians as it is one of the most common primary glomerular diseases in the world, particularly prevalent in Asian and African populations. Its early diagnosis and management can prevent the progression to end-stage renal disease.